Opaleye Management

Latest statistics and disclosures from Opaleye Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Opaleye Management

Companies in the Opaleye Management portfolio as of the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ocular Therapeutix (OCUL) 15.6 $106M 6.5M 16.41
Chimerix (CMRX) 6.4 $43M +13% 4.5M 9.64
Protara Therapeutics Com Stk (TARA) 5.9 $40M 2.6M 15.74
Bridgebio Pharma (BBIO) 5.3 $36M NEW 584k 61.60
Codexis (CDXS) 4.7 $32M 1.4M 22.89
Eton Pharmaceuticals (ETON) 4.3 $30M 4.0M 7.32
Macrogenics (MGNX) 3.1 $21M +79% 666k 31.85
Tracon Pharmaceuticals Com New (TCON) 3.0 $21M 2.5M 8.23
Harrow Health (HROW) 3.0 $21M 3.1M 6.75
Celldex Therapeutics Com New (CLDX) 3.0 $20M 985k 20.60
Xoma Corp Del Com New (XOMA) 2.6 $18M -3% 438k 40.81
Stereotaxis Com New (STXS) 2.5 $17M -16% 2.5M 6.72
Neoleukin Therapeutics (NLTX) 2.2 $15M -11% 1.2M 12.31
Fortress Biotech (FBIO) 2.0 $14M 3.9M 3.53

Setup an alert

Opaleye Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Cytokinetics Com New (CYTK) 2.0 $14M 580k 23.26
Autolus Therapeutics Sponsored Ads (AUTL) 1.8 $12M NEW 2.1M 5.73
Gemini Therapeutics 1.6 $11M NEW 811k 13.55
Deciphera Pharmaceuticals (DCPH) 1.5 $10M 222k 44.84
Seres Therapeutics (MCRB) 1.4 $9.8M -10% 300k 32.68
Keros Therapeutics (KROS) 1.4 $9.7M NEW 158k 61.55
Checkpoint Therapeutics (CKPT) 1.3 $9.2M NEW 2.9M 3.14
Proqr Therapeutics Nv Shs Euro (PRQR) 1.3 $8.6M NEW 1.3M 6.61
Essa Pharma Com New (EPIX) 1.2 $8.3M 284k 29.05
Acutus Medical (AFIB) 1.2 $8.2M -18% 615k 13.37
Adamas Pharmaceuticals (ADMS) 1.2 $8.0M +12% 1.7M 4.80
Cerecor (CERC) 1.2 $7.9M 2.6M 3.02
Sutro Biopharma (STRO) 1.1 $7.8M +6% 342k 22.76
Protagonist Therapeutics (PTGX) 1.1 $7.7M +14% 297k 25.90
Immunovant (IMVT) 1.1 $7.5M NEW 467k 16.04
Vaxcyte (PCVX) 1.0 $7.1M +6% 358k 19.75
Sanara Medtech (SMTI) 1.0 $7.0M NEW 225k 31.15
Catalyst Biosciences Com New (CBIO) 0.9 $6.3M +740% 1.3M 5.04
Aveo Biosciences Com New (AVEO) 0.9 $6.1M +1320% 835k 7.32
Kiniksa Pharmaceuticals Com Cl A (KNSA) 0.9 $5.9M +43% 321k 18.51
Verastem (VSTM) 0.8 $5.7M 2.3M 2.47
Tela Bio (TELA) 0.8 $5.4M 365k 14.90
Mei Pharma Com New (MEIP) 0.8 $5.3M 1.6M 3.43
Cardiff Oncology (CRDF) 0.8 $5.3M -65% 576k 9.26
Sio Gene Therapies (SIOX) 0.8 $5.2M 2.0M 2.61
Aptose Biosciences Com New (APTO) 0.8 $5.2M +8% 872k 5.97
Myovant Sciences (MYOV) 0.8 $5.1M -63% 250k 20.58
Fibrogen (FGEN) 0.7 $5.1M 147k 34.71
Lumos Pharma (LUMO) 0.6 $4.4M +33% 377k 11.70
Kezar Life Sciences (KZR) 0.6 $4.2M 711k 5.96
Optinose (OPTN) 0.4 $3.0M +89% 826k 3.69
Highcape Capital Acquisition Corp Com Cl A (CAPA) 0.4 $2.9M NEW 241k 11.92
Crinetics Pharmaceuticals In (CRNX) 0.4 $2.9M NEW 188k 15.28
Edap Tms Sa Sponsored Adr (EDAP) 0.4 $2.9M -48% 341k 8.40
Sierra Oncology Com New (SRRA) 0.4 $2.6M +100% 151k 17.23
Biohaven Pharmaceutical Holding (BHVN) 0.3 $1.7M -78% 25k 68.36
Alpine Immune Sciences (ALPN) 0.2 $1.7M NEW 157k 10.60
Aerpio Pharmaceuticals (ARPO) 0.2 $1.3M NEW 1.0M 1.29
Ayala Pharmaceuticals Incorporated (AYLA) 0.2 $1.2M NEW 109k 10.91
Contrafect Corp Com New (CFRX) 0.2 $1.2M -44% 244k 4.80
Magenta Therapeutics (MGTA) 0.2 $1.0M +84% 88k 11.84
Viracta Therapeutics 0.1 $958k NEW 104k 9.25
Leap Therapeutics (LPTX) 0.1 $737k NEW 388k 1.90
Biolinerx Sponsored Ads (BLRX) 0.0 $47k 17k 2.82

Past Filings by Opaleye Management

SEC 13F filings are viewable for Opaleye Management going back to 2013

View all past filings